DNA & SOLUBLE MULTIMERIC IMMUNOGEN FOR HUMMORAL IMMUNITY
DNA & SOLUBLE MULTIMERIC IMMUNOGEN FOR HUMMORAL IMMUNITY
批准号:
2887880
负责人:
JON OSCHERWITZ
金额:
$18.9万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-29 至 2002-06-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract): Earlier work in a number
of disease models has shown that immunogens containing tandemly repeated
epitopes can be more immunogenic than a respective immunogen containing only
a single copy of the sequence. The applicant's studies have revealed that
antisera raised in mice to a recombinant immunogen in alum containing eight
copies of an MN isolate V3PND sequence is able to neutralize ADA, a primary
M-tropic isolate of HIV-I. However, despite hopes of generating immunogens
able to induce antibodies capable of primary isolate neutralization, the
hypervariable nature of the V3 loop of HIV would apparently necessitate
incorporation of multiple strain specific V3 loop sequences in any prototype
AIDS vaccine. Coincident with the increased understanding of the role of
the V3 loop in determining cellular tropism, however, has come new insights
into how the V3loop sequences interact with cellular coreceptors in the
facilitation of HIV infection.
CCR5 is a G-protein coupled receptor identified as integral for entry by
M-tropic HIV isolates into macrophages. Since M-tropic viral isolates are
especially implicated early in HIV infection and individuals who are
homozygous for the 32 bp deletion which results in a non-functional-CCR5
receptor are protected from infection from HIV, yet appear to have a normal
phenotype, the CCR5 extracellular receptor sequences represent attractive
targets for humoral immunity to HIV-I. We have analyzed the CCR5
extracellular receptor sequence domains and have identified putative
extracellular sequences which represent potential antibody targets. The
major objectives of the current study are to: a) Develop tandem repeat
soluble and DNA constructs representing sequences from the V3 loop of
primary NSI M-tropic isolates; b) Analyze the ability of antisera to these
constructs raised in BALB/c mice to neutralize homologous and heterologous
primary NSI M-tropic HIV isolates; c) Develop tandem repeat soluble and DNA
constructs representing sequences from the putative extracellular domains of
CCR5; d) Analyze the ability of antisera to these constructs raised in
BALB/c mice to neutralize homologous and heterologous primary NSI M-tropic
HIV isolates and; e)Utilizing the results from targeting the V3 and CCR5
sequences, construct hybrid immunogens which contain sequences from both the
V3 loop of primary NSI M-tropic viruses, and immunogenic sequences from the
CCR5 coreceptor. The construction of these immunogens is enabled by our
development of BMX7, a novel vector for cloning multi-determinant tandem
repeat immunogens, and BMX7EX, a DNA expression vector which retains the
essential cloning features of the BMX7 vector. These studies will ideally
culminate in the development of immunogens capable of inducing antibodies
able to neutralize M-tropic primary isolate infectivity and contribute
significantly to our understanding of the immunology of peptide component
DNA and soluble immunogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A multivalent vaccine for Staphylococcus aureus
-
批准号:10515340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JON OSCHERWITZ
-
依托单位:
A multivalent vaccine for Staphylococcus aureus
-
批准号:10057219
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JON OSCHERWITZ
-
依托单位:
A multivalent vaccine for Staphylococcus aureus
-
批准号:10421262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JON OSCHERWITZ
-
依托单位:
A molecularly targeted pre- and post-exposure vaccine for anthrax
-
批准号:8781529
-
项目类别:
-
资助金额:$26.02万
-
财政年份:2014
-
负责人:JON OSCHERWITZ
-
依托单位:
A molecularly targeted pre- and post-exposure vaccine for anthrax
-
批准号:8889624
-
项目类别:
-
资助金额:$24.96万
-
财政年份:2014
-
负责人:JON OSCHERWITZ
-
依托单位:
DNA & SOLUBLE MULTIMERIC IMMUNOGEN FOR HUMMORAL IMMUNITY
-
批准号:2751241
-
项目类别:
-
资助金额:$18.9万
-
财政年份:1998
-
负责人:JON OSCHERWITZ
-
依托单位:
海外基金